A previous study indicated that the onset of cardiac hypertrophy critically depends upon activation of MAPKs [26], and recent work demonstrated that CTGF activate numerous MAPKs, including ERK1/2, JNK, and p38 kinases [5]. This evidence concerns the gene CCN2 and cardiac hypertrophy.